Braeburn

FromSabrina Romano ([email protected])
Subject (150)Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a Phase 3 Efficacy and Safety Study
Preheader (150)View this email in your browser Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a P
Typography
Helvetica
Colors
Text Analysis
Body Words2844
Subject Words25
Body Emojis1
Subject Emojis
Media Analysis
Text Links13
Image Links
Total Links13
Images2
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px4421 px
X-Spam Score-1.4
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening

Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a Phase 3 Efficacy and Safety Study

View this email in your browser Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a P
Braeburn Announces Publication of a Post Hoc Analysis of Data from Patients Using Fentanyl Treated with BRIXADI in a Phase 3 Efficacy and Safety Study